Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Boulder, CO
SEC filing record 1 source field available
Fiscal year end
31 March
Sonoma Pharmaceuticals, Inc. has filed 974 SEC EDGAR filings since 15 Jan 2002

SEC filing history

Showing 226-250 of 746 matching filings.

Per page
25
Current page
10
4

4 filing

Filing date
24 Apr 2020
Reporting date
23 Apr 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
3

3 filing

Filing date
23 Apr 2020
Reporting date
14 Apr 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-33216

FORM 8-K

Filing date
20 Apr 2020
Reporting date
14 Apr 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-33216

CURRENT REPORT

Filing date
27 Feb 2020
Reporting date
21 Feb 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
25-NSE File 001-33216

25-NSE filing

Filing date
22 Jan 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
03 Jan 2020
Reporting date
31 Dec 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
03 Jan 2020
Reporting date
31 Dec 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-33216

FORM 8-K

Filing date
31 Dec 2019
Reporting date
26 Dec 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
S-8 File 333-235708

FORM S-8

Filing date
26 Dec 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-33216

FORM 8-K

Filing date
29 Nov 2019
Reporting date
26 Nov 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
424B3 File 333-221477

PROSPECTUS SUPPLEMENT

Filing date
27 Nov 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
424B3 File 333-221477

PROSPECTUS SUPPLEMENT

Filing date
26 Nov 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-33216

FORM 8-K

Filing date
06 Nov 2019
Reporting date
05 Nov 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
DEFA14A File 001-33216

DEFA14A

Filing date
18 Oct 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
3

3 filing

Filing date
17 Oct 2019
Reporting date
27 Sep 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-33216

FORM 8-K

Filing date
15 Oct 2019
Reporting date
08 Oct 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
3

3 filing

Filing date
15 Oct 2019
Reporting date
27 Sep 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
DEFA14A File 001-33216

ADDITIONAL PROXY MATERIALS

Filing date
09 Oct 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
DEFA14A File 001-33216

ADDITIONAL MATERIALS

Filing date
03 Oct 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-33216

FORM 8-K

Filing date
01 Oct 2019
Reporting date
25 Sep 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
DEFA14A File 001-33216

DEFINITIVE ADDITIONAL PROXY MATERIALS

Filing date
18 Sep 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
DEF 14A File 001-33216

NOTICE AND PROXY STATEMENT

Filing date
29 Jul 2019
Reporting date
17 Sep 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .